Invitae, based in San Francisco, is a genetic information company whose mission is to bring genetic information into routine medical practice to improve the quality of healthcare. Specializing in genetic diagnostics for hereditary disorders, Invitae's goal is to aggregate the world's genetic tests into a single service with better quality, faster turnaround time, and a lower price than many single-gene diagnostic tests today. The company currently provides a single diagnostic test comprising over 200 genes for a variety of genetic disorders associated with cancer, cardiology, neurology and pediatrics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 10/13/14 | $120,000,000 | Series F |
Broe Group Casdin Capital Decheng Capital Deerfield Management Company, L.P. Genesys Capital Genomic Health OrbiMed Advisors Perceptive Advisors Redmile Group Rock Springs Capital Thomas McNerney & Partners Wellington Management Company | undisclosed |
